Finasteride, an FDA-approved therapeutic agent, plays a pivotal role in managing benign prostate hyperplasia and androgenic alopecia (male pattern hair loss) in men. Through its competitive inhibition of 5-alpha-reductase (types II and III isoenzymes), finasteride impedes the conversion of testosterone to dihydrotestosterone (DHT), addressing the underlying pathophysiology of these conditions. This activity discusses finasteride’s diverse applications, extending beyond its primary indications to treat hyperandrogenism-associated manifestations, such as hirsutism.Additionally, the module explores the potential utilization of finasteride in transgender women, particularly when combined with estrogen, harnessing its anti-androgenic properties. The program outlines the recommended dosing, highlights significant adverse effects, identifies contraindications, and elucidates the essential aspects of monitoring and managing potential toxicity. By imparting an understanding of finasteride’s mechanisms and clinical applications, this activity empowers healthcare providers to navigate patient therapy effectively, guiding them toward optimal outcomes.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/21771
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Chemical Pathology, General Surgery, Internal Medicine, Male Genital